Active ingredient
Latanoprost 50 micrograms/ml.
Indications
Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension in adults (including elderly patients). Reduction of elevated IOP in pediatric patients with elevated IOP and pediatric glaucoma.
Presentation
30 single-dose containers of 0.4 ml of eye drops in solution.
Dosage
The recommended therapeutic dose is one drop in the affected eye(s) once a day. The optimal effect is obtained if latanoprost is administered at night. For single use only. Discard any unused solution immediately after use.